DUBLIN–(BUSINESS WIRE)–The “ResMed Inc (RMD) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. ThisDUBLIN–(BUSINESS WIRE)–The “ResMed Inc (RMD) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering. This

ResMed (RMD) Product Pipeline Analysis Report 2025 – ResearchAndMarkets.com

2026/01/01 00:30
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

DUBLIN–(BUSINESS WIRE)–The “ResMed Inc (RMD) – Product Pipeline Analysis, 2025 Update” company profile has been added to ResearchAndMarkets.com’s offering.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices.

The company distributes its products in various countries through a combination of distributors and direct sales teams. ResMed also offers software as a service (SaaS) to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers. ResMed is headquartered in San Diego, California, the US.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Report Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company ResMed Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

ResMed Inc, Recent Developments

  • Dec 19, 2025: ResMed Receives FDA 510(k) Clearance for Personalized Therapy Comfort Settings (PTCS)
  • Dec 08, 2025: Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
  • Nov 19, 2025: Abigail Uttley Joins Inhealthcare as Project Manager
  • Oct 13, 2025: Fractus Files Patent Infringement Complaint Against ResMed in Southern District of California
  • Oct 01, 2025: Amy Frith Appointed Customer Success Manager for NHS Digital Health Partnerships at Inhealthcare
  • Sep 03, 2025: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
  • Aug 21, 2025: Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
  • Aug 18, 2025: Resmed Appoints Nicole Mowad-Nassar to Board of Directors
  • Jul 21, 2025: Oxygen Therapy Devices Market Set for Steady Expansion by 2032, Driven by Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical, Hamilton Medical, Neote
  • Jun 10, 2025: ResMed Receives Additional 510(K) Clearance For AirFit F20

Key Topics Covered:

  • ResMed Inc Company Overview
  • ResMed Inc Company Snapshot
  • ResMed Inc Pipeline Products and Ongoing Clinical Trials Overview
  • ResMed Inc – Pipeline Analysis Overview
  • Business Description
  • ResMed Inc – Key Facts
  • ResMed Inc – Major Products and Services
  • ResMed Inc Pipeline Products by Development Stage
  • ResMed Inc Ongoing Clinical Trials by Trial Status
  • ResMed Inc Pipeline Products Overview
  • AirCurve 11 ASV – Insomnia
  • AirCurve 11 ASV – Insomnia Product Overview
  • AirCurve 11 ASV – Insomnia Clinical Trial
  • AirFit F40
  • AirFit F40 Product Overview
  • Breezhaler Inhaler – Add On Sensor
  • Breezhaler Inhaler – Add On Sensor Product Overview
  • Connected Metered Dose Inhaler
  • Connected Metered Dose Inhaler Product Overview
  • Leo
  • Leo Product Overview
  • Masksense
  • Masksense Product Overview
  • Mitigait
  • Mitigait Product Overview
  • Monterey Pneumatic Compression Device
  • Monterey Pneumatic Compression Device Product Overview
  • Personalized Therapy Comfort Settings (PTCS)
  • Personalized Therapy Comfort Settings (PTCS) Product Overview
  • Smart Device – Cardiac Health
  • Smart Device – Cardiac Health Product Overview
  • ResMed Inc – Key Competitors
  • ResMed Inc – Key Employees
  • ResMed Inc – Key Employee Biographies
  • ResMed Inc – Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Appendix

For more information about this company profile visit https://www.researchandmarkets.com/r/x0z25

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.06112
$0.06112$0.06112
+0.31%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Hyperliquid the new frontier for innovation?

Is Hyperliquid the new frontier for innovation?

The post Is Hyperliquid the new frontier for innovation? appeared on BitcoinEthereumNews.com. This is a segment from the 0xResearch newsletter. To read full editions, subscribe. One of the key things I like to track in crypto is a subjective criterion I call “where are new interesting developments and proposals taking place.” There are plenty of dashboards and analytics sites for this, the most popular being the Electric Capital site. The issue is that it still shows Polkadot as having a lot of developers. (At Blockworks we solved the noise problem with active users; maybe we can try the same for active developers.) Because of this noise, I prefer to track two simple observations: What is the velocity of new products launching, and how much mindshare are these products capturing? Are many people getting nerdsniped into discussing the novelties and intricacies of the chain? A related point is the caliber of people being attracted to new ecosystems. For example, over the past few years, Solana (and Ethereum) attracted the majority of talent. Talent generally goes where: It can solve interesting problems or create interesting projects. It can make a lot of money. In a podcast I did with Icebergy about a year ago, we discussed how crypto still wasn’t attracting talent at the levels AI was, despite offering faster exits and more money. AI was (and probably still is) more interesting to most talent and seen as more prestigious. After FTX, crypto lost a lot of credibility and has only recently started recovering as larger institutional players re-entered. Apart from FTX, crypto has also been criticized for being full of low-effort forks and limited utility products. This dynamic isn’t unique to crypto though. Many AI companies are also just building wrappers around GPT, which is as uninteresting as some projects in crypto. Anyway, to the point: Historically, Solana has captured the majority of…
Share
BitcoinEthereumNews2025/09/18 08:13
Why More Startups Are Automating Their HR Processes in 2025

Why More Startups Are Automating Their HR Processes in 2025

  Startups in 2025 are moving faster than ever. With lean teams, remote workforces, and aggressive growth goals, manual HR management no longer fits the modern
Share
Techbullion2026/03/08 15:29
Shiba Inu Records -131 Billion in 24 Hours: Negative Netflow Signals Growing Demand

Shiba Inu Records -131 Billion in 24 Hours: Negative Netflow Signals Growing Demand

The post Shiba Inu Records -131 Billion in 24 Hours: Negative Netflow Signals Growing Demand appeared on BitcoinEthereumNews.com. SHIB exchange flow is hinting
Share
BitcoinEthereumNews2026/03/08 15:30